Strata Critical Medical, Inc.
SRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -30.4% | 30.4% | -0.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.6% | 25.1% | 22.1% | 23.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.7% | -4.5% | -10.8% | -12.6% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 116.5% | -5.3% | -6.4% | -18% |
| EPS Diluted | 0.7 | -0.046 | -0.04 | -0.12 |
| % Growth | 1,621.7% | -15% | 66.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |